Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1005629.RAEYY2OQJMEbf69vv-QhI8JavfF-IPVIRnTzXESv2gCqc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1005629.RAEYY2OQJMEbf69vv-QhI8JavfF-IPVIRnTzXESv2gCqc130_assertion type Assertion NP1005629.RAEYY2OQJMEbf69vv-QhI8JavfF-IPVIRnTzXESv2gCqc130_head.
- NP1005629.RAEYY2OQJMEbf69vv-QhI8JavfF-IPVIRnTzXESv2gCqc130_assertion description "[Recurrent somatic ASXL1 mutations occur in patients with myelodysplastic syndrome, myeloproliferative neoplasms, and acute myeloid leukemia, and are associated with adverse outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1005629.RAEYY2OQJMEbf69vv-QhI8JavfF-IPVIRnTzXESv2gCqc130_provenance.
- NP1005629.RAEYY2OQJMEbf69vv-QhI8JavfF-IPVIRnTzXESv2gCqc130_assertion evidence source_evidence_literature NP1005629.RAEYY2OQJMEbf69vv-QhI8JavfF-IPVIRnTzXESv2gCqc130_provenance.
- NP1005629.RAEYY2OQJMEbf69vv-QhI8JavfF-IPVIRnTzXESv2gCqc130_assertion SIO_000772 22897849 NP1005629.RAEYY2OQJMEbf69vv-QhI8JavfF-IPVIRnTzXESv2gCqc130_provenance.
- NP1005629.RAEYY2OQJMEbf69vv-QhI8JavfF-IPVIRnTzXESv2gCqc130_assertion wasDerivedFrom befree-2016 NP1005629.RAEYY2OQJMEbf69vv-QhI8JavfF-IPVIRnTzXESv2gCqc130_provenance.
- NP1005629.RAEYY2OQJMEbf69vv-QhI8JavfF-IPVIRnTzXESv2gCqc130_assertion wasGeneratedBy ECO_0000203 NP1005629.RAEYY2OQJMEbf69vv-QhI8JavfF-IPVIRnTzXESv2gCqc130_provenance.